Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized …
A Tursi, G Brandimarte, A Papa, A Giglio… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: VSL# 3 is a high-potency probiotic mixture that has been used successfully
in the treatment of pouchitis. The primary end point of the study was to assess the effects of …
in the treatment of pouchitis. The primary end point of the study was to assess the effects of …
High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal
A Tursi, G Brandimarte, GM Giorgetti - Official journal of the …, 2003 - journals.lww.com
OBJECTIVE: Celiac disease is a gluten-sensitive enteropathy with a broad spectrum of clinical
manifestation, and most celiac patients respond to a gluten-free diet (GFD). However, in …
manifestation, and most celiac patients respond to a gluten-free diet (GFD). However, in …
Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease
A Tursi, G Brandimarte, GM Giorgetti - Journal of clinical …, 2003 - journals.lww.com
Results Marsh I lesions were present in 13 patients (10.92%), Marsh II in 24 anti-tTG (20.16%),
Marsh IIIa in 27 anti-tTG (22.68%), Marsh IIIb in 31 anti-tTG (26.05%) and Marsh IIIc in 24 …
Marsh IIIa in 27 anti-tTG (22.68%), Marsh IIIb in 31 anti-tTG (26.05%) and Marsh IIIc in 24 …
Faecal calprotectin in colonic diverticular disease: a case–control study
A Tursi, G Brandimarte, W Elisei, GM Giorgetti… - International journal of …, 2009 - Springer
Background and aims Information about faecal calprotectin (FC) in colonic diverticular
disease (DD) are lacking. We assessed FC in colonic DD, comparing it with irritable bowel …
disease (DD) are lacking. We assessed FC in colonic DD, comparing it with irritable bowel …
Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open …
A Tursi, G Brandimarte, GM Giorgetti… - Journal of clinical …, 2006 - journals.lww.com
Background Both mesalazine and probiotics showed recently their effectiveness in obtaining
remission of symptomatic uncomplicated diverticular disease of the colon. Consistent data …
remission of symptomatic uncomplicated diverticular disease of the colon. Consistent data …
[HTML][HTML] Interactions between innate immunity, microbiota, and probiotics
GM Giorgetti, G Brandimarte, F Fabiocchi… - Journal of immunology …, 2015 - hindawi.com
The term “microbiota” means genetic inheritance associated with microbiota, which is about
100 times larger than the guest. The tolerance of the resident bacterial flora is an important …
100 times larger than the guest. The tolerance of the resident bacterial flora is an important …
Assessment and grading of mucosal inflammation in colonic diverticular disease
A Tursi, G Brandimarte, W Elisei… - Journal of clinical …, 2008 - journals.lww.com
Background Mucosal inflammation in colonic DD has never been investigated. In particular,
it is unknown whether inflammation may be found in every degree of DD. Materials and …
it is unknown whether inflammation may be found in every degree of DD. Materials and …
[HTML][HTML] Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease
…, E Roda, F Pistoia, G Brandimarte… - World journal of …, 2007 - ncbi.nlm.nih.gov
AIM: To comparatively evaluate the long term efficacy of Rifaximin and dietary fibers in
reducing symptoms and/or complication frequency in symptomatic, uncomplicated diverticular …
reducing symptoms and/or complication frequency in symptomatic, uncomplicated diverticular …
Assessment of fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon
…, GM Giorgetti, F Fabiocchi, G Brandimarte - Journal of clinical …, 2016 - journals.lww.com
Background: Whether intestinal microbiota and metabolic profiling may be altered in patients
with SUDD is unknown. Patients and Methods: Stool samples from 44 consecutive women […
with SUDD is unknown. Patients and Methods: Stool samples from 44 consecutive women […
Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease
A Tursi, G Brandimarte, GM Giorgetti - Journal of clinical …, 2003 - journals.lww.com
Gluten-free diet (GFD) plays a key role in the treatment of celiac disease (CD), but it is difficult
to evaluate the effect of GFD on the improvement of villous architecture using sensitive, non…
to evaluate the effect of GFD on the improvement of villous architecture using sensitive, non…